BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 3018088)

  • 1. Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis.
    Nanney LB; Stoscheck CM; Magid M; King LE
    J Invest Dermatol; 1986 Mar; 86(3):260-5. PubMed ID: 3018088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased high-affinity epidermal growth factor receptors in psoriatic epidermis.
    Urano Y; Ikeuchi T; Fujimoto A; Asano T; Arase S; Shigemi F; Takeda K
    Tokushima J Exp Med; 1989 Dec; 36(3-4):53-8. PubMed ID: 2636999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of EGF receptor expressing and DNA replicating epidermal cells in psoriasis vulgaris and Bowen's disease.
    Amagai M; Ozawa S; Ueda M; Nishikawa T; Abe O; Shimizu N
    Br J Dermatol; 1988 Nov; 119(5):661-8. PubMed ID: 3207620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of epidermal growth factor receptors in psoriatic lesions during treatment with topical EGF.
    Nanney LB; Yates RA; King LE
    J Invest Dermatol; 1992 Mar; 98(3):296-301. PubMed ID: 1545139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor.
    Krane JF; Gottlieb AB; Carter DM; Krueger JG
    J Exp Med; 1992 Apr; 175(4):1081-90. PubMed ID: 1313074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes.
    Piepkorn M; Predd H; Underwood R; Cook P
    Arch Dermatol Res; 2003 Jul; 295(3):93-101. PubMed ID: 12768307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages.
    Nanney LB; Magid M; Stoscheck CM; King LE
    J Invest Dermatol; 1984 Nov; 83(5):385-93. PubMed ID: 6092481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased epidermal growth factor receptor in fsn/fsn mice.
    Nanney LB; Sundberg JP; King LE
    J Invest Dermatol; 1996 Jun; 106(6):1169-74. PubMed ID: 8752652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in human skin between the epidermal growth factor receptor distribution detected by EGF binding and monoclonal antibody recognition.
    Green MR; Couchman JR
    J Invest Dermatol; 1985 Sep; 85(3):239-45. PubMed ID: 2411822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of ribosomal protein S6 kinase in psoriatic lesions and cultured human keratinocytes by epidermal growth factor receptor ligands.
    Choi JH; O'Connor TP; Kang S; Voorhees JJ; Fisher GJ
    J Invest Dermatol; 1997 Jan; 108(1):98-102. PubMed ID: 8980296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration and significance of heparin-binding epidermal-growth-factor-like growth factor in psoriatic epidermis.
    Zheng Y; Peng Z; Wang Y; Tan S; Xi Y; Wang G
    Dermatology; 2003; 207(1):22-7. PubMed ID: 12835543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of transforming growth factor-alpha (TGF-alpha) and EGF receptor in transitional area of psoriatic epidermis.
    Higashiyama M; Hashimoto K; Matsumoto K; Yoshikawa K
    J Dermatol Sci; 1994 Feb; 7(1):45-53. PubMed ID: 7514888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization of epidermal growth factor receptors in human epidermis.
    Nanney LB; McKanna JA; Stoscheck CM; Carpenter G; King LE
    J Invest Dermatol; 1984 Feb; 82(2):165-9. PubMed ID: 6319502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal distribution of epidermal protein antigens in psoriatic epidermis.
    Watanabe S; Wagatsuma K; Ichikawa E; Takahashi H
    J Dermatol; 1991 Mar; 18(3):143-51. PubMed ID: 1715894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase.
    Forsberg S; Ostman A; Rollman O
    Arch Dermatol Res; 2008 Oct; 300(9):505-16. PubMed ID: 18446355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor and temperature regulate keratinocyte differentiation.
    Ponec M; Gibbs S; Weerheim A; Kempenaar J; Mulder A; Mommaas AM
    Arch Dermatol Res; 1997 May; 289(6):317-26. PubMed ID: 9209676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered binding of Ulex europaeus I lectin to psoriatic epidermis.
    Kariniemi AL; Holthöfer H; Miettinen A; Virtanen I
    Br J Dermatol; 1983 Nov; 109(5):523-9. PubMed ID: 6357263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural localization of calcium in psoriatic and normal human epidermis.
    Menon GK; Elias PM
    Arch Dermatol; 1991 Jan; 127(1):57-63. PubMed ID: 1986708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light microscopic autoradiographical analysis of [125I]epidermal growth factor binding in basal cell epithelioma and squamous cell carcinoma of the skin.
    Ikeuchi T; Urano Y; Fukuhara K; Nakanishi H; Arase S
    J Dermatol; 1993 Apr; 20(4):219-25. PubMed ID: 8315111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.